Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis - Concepedia

Concepedia

Publication | Closed Access

Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis

36

Citations

26

References

2012

Year

Toshihisa Kojima, Yuichiro Yabe, Atsushi Kaneko, Y. Hirano, Hisato Ishikawa, Masatoshi Hayashi, Hiroyuki Miyake, Hideki Takagi, Takefumi Kato, Kenya Terabe,

Modern Rheumatology

Abstract

Adequate suppression of pathological IL-6 signalling during TCZ treatment improves clinical outcomes and can be monitored with serum CRP levels, a readily available biomarker in clinical practice.

References

	Year	Citations

Page 1